Roanoke Asset Management’s Celgene Corp CELG Stock Holding History

Roanoke Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,000	Closed	-$200K	–	104
2016 Q1	$200K	Hold	2,000	–	–	0.09%	96
2015 Q4	$240K	Hold	2,000	–	–	0.1%	94
2015 Q3	$216K	Sell	2,000 -150	-7%	-$18.6K	0.08%	103
2015 Q2	$249K	Sell	2,150 -550	-20%	-$62.9K	0.08%	103
2015 Q1	$311K	Sell	2,700 -1,200	-31%	-$143K	0.1%	95
2014 Q4	$436K	Sell	3,900 -80	-2%	-$8.44K	0.15%	84
2014 Q3	$377K	Hold	3,980	–	–	0.15%	83
2014 Q2	$342K	Hold	3,980	–	–	0.13%	86
2014 Q1	$278K	Hold	3,980	–	–	0.12%	91
2013 Q4	$336K	Hold	3,980	–	–	0.15%	84
2013 Q3	$297K	Buy	+3,980	New	+$279K	0.14%	86

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Roanoke Asset Management's CELG Position: Q2 2016 in Review

Roanoke Asset Management sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 2,000 shares — an estimated $200K sold.

Roanoke Asset Management first reported a position in CELG in Q3 2013 and held it in 11 quarters. The position peaked at $436K in Q4 2014. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Roanoke Asset Management reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
Roanoke Asset Management sold 2,000 Celgene Corp shares in Q2 2016, an estimated $200K.
Roanoke Asset Management first reported a position in Celgene Corp in Q3 2013 and held it in 11 quarters.
Roanoke Asset Management's Celgene Corp position peaked at $436K in Q4 2014.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Roanoke Asset Management's 13F filing for Q2 2016, filed 2 Aug 2016.